{
    "abstract": "Background: Herpes zoster (HZ) risk appears to vary by sex and geographic ancestry/ethnicity. Methods: In 2 randomized clinical trials, participants received 2 doses of adjuvanted recombinant zoster vaccine (RZV) or placebo intramuscularly, 2 months apart. In this post-hoc analysis, we investigate efficacy of RZV against HZ and postherpetic neuralgia (PHN) by sex, geographic region, and geographic ancestry/ethnicity in \u226550-year-olds (ZOE-50: NCT01165177) and \u226570-year-olds (pooled data from ZOE-50 and ZOE-70: NCT01165229). Results: Vaccine efficacy against HZ or PHN was similar in women and men. Across geographic regions, efficacy against HZ ranged between 95.7 and 97.2% in \u226550-year-olds, and between 87.3% and 95.1% in \u226570-year-olds; efficacy against PHN ranged between 86.8 and 100% in \u226570-year-olds. Across ancestral/ethnic groups, efficacy ranged between 88.1 and 100% against HZ and between 65.9 and 100% against PHN in \u226570-year-olds. Conclusions: While the ZOE-50/70 studies were not powered or pre-designed for these post-hoc analyses, RZV appears efficacious against HZ and PHN irrespective of sex, region, or geographic ancestry/ethnicity.",
    "author_highlights": [
        {
            "endOffset": 14196,
            "sentence": "RZV efficacy against HZ or PHN was similar in women and men.",
            "startOffset": 14136
        },
        {
            "endOffset": 14276,
            "sentence": "In \u226550-year-olds, efficacy against HZ was 95.7\u201397.2% across geographic regions.",
            "startOffset": 14197
        },
        {
            "endOffset": 14363,
            "sentence": "In \u226570-year-olds, efficacy against HZ and PHN was 86.8\u2013100% across geographic regions.",
            "startOffset": 14277
        },
        {
            "endOffset": 14455,
            "sentence": "No major efficacy differences observed against HZ and PHN by geographic ancestry/ethnicity.",
            "startOffset": 14364
        },
        {
            "endOffset": 14558,
            "sentence": "RZV efficacy against HZ and PHN in these subsets was consistent with the overall ZOE-50/70 population.",
            "startOffset": 14456
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Kosuke",
                    "initial": "K.",
                    "last": "Kawai"
                },
                {
                    "first": "Berhanu G.",
                    "initial": "B.G.",
                    "last": "Gebremeskel"
                },
                {
                    "first": "Camilo J.",
                    "initial": "C.J.",
                    "last": "Acosta"
                }
            ],
            "doi": "10.1136/bmjopen-2014-004833",
            "issn": "20446055",
            "pmid": "24916088",
            "pub_year": 2014,
            "title": "Systematic review of incidence and complications of herpes zoster: Towards a global perspective",
            "volume": "4"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Johnson"
                },
                {
                    "first": "Didier",
                    "initial": "D.",
                    "last": "Bouhassira"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Kassianos"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Lepl\u00e8ge"
                },
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Weinke"
                }
            ],
            "doi": "10.1186/1741-7015-8-37",
            "issn": "17417015",
            "pmid": "20565946",
            "pub_year": 2010,
            "title": "The impact of herpes zoster and post-herpetic neuralgia on quality-of-life",
            "volume": "8"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Sloane"
                },
                {
                    "first": "Carl",
                    "initial": "C.",
                    "last": "Pieper"
                },
                {
                    "first": "Paul M.",
                    "initial": "P.M.",
                    "last": "Coplan"
                },
                {
                    "first": "Alexander",
                    "initial": "A.",
                    "last": "Nikas"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Saddier"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Choo"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Johnson"
                },
                {
                    "first": "Heather M.",
                    "initial": "H.M.",
                    "last": "Williams"
                },
                {
                    "first": "Michael N.",
                    "initial": "M.N.",
                    "last": "Oxman"
                }
            ],
            "doi": "10.1097/AJP.0b013e318065b6c9",
            "firstpage": "490",
            "issn": "07498047",
            "lastpage": "496",
            "pmid": "17575488",
            "pub_year": 2007,
            "title": "The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults",
            "volume": "23"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Kosuke",
                    "initial": "K.",
                    "last": "Kawai"
                },
                {
                    "first": "Emmanouil",
                    "initial": "E.",
                    "last": "Rampakakis"
                },
                {
                    "first": "Tsen Fang",
                    "initial": "T.F.",
                    "last": "Tsai"
                },
                {
                    "first": "Hee Jin",
                    "initial": "H.J.",
                    "last": "Cheong"
                },
                {
                    "first": "Jittima",
                    "initial": "J.",
                    "last": "Dhitavat"
                },
                {
                    "first": "Alejandro Ortiz",
                    "initial": "A.O.",
                    "last": "Covarrubias"
                },
                {
                    "first": "Lin",
                    "initial": "L.",
                    "last": "Yang"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "Cashat-Cruz"
                },
                {
                    "first": "Homero",
                    "initial": "H.",
                    "last": "Monsanto"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Johnson"
                },
                {
                    "first": "John S.",
                    "initial": "J.S.",
                    "last": "Sampalis"
                },
                {
                    "first": "Camilo J.",
                    "initial": "C.J.",
                    "last": "Acosta"
                }
            ],
            "doi": "10.1016/j.ijid.2015.03.022",
            "firstpage": "126",
            "issn": "12019712",
            "lastpage": "131",
            "pmid": "25841633",
            "pub_year": 2015,
            "title": "Predictors of postherpetic neuralgia in patients with herpes zoster: A pooled analysis of prospective cohort studies from North and Latin America and Asia",
            "volume": "34"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Barbara P.",
                    "initial": "B.P.",
                    "last": "Yawn"
                },
                {
                    "first": "Don",
                    "initial": "D.",
                    "last": "Gilden"
                }
            ],
            "doi": "10.1212/WNL.0b013e3182a3516e",
            "firstpage": "928",
            "issn": "00283878",
            "lastpage": "930",
            "pmid": "23999562",
            "pub_year": 2013,
            "title": "Global perspectives",
            "volume": "81"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Kosuke",
                    "initial": "K.",
                    "last": "Kawai"
                },
                {
                    "first": "Barbara P.",
                    "initial": "B.P.",
                    "last": "Yawn"
                }
            ],
            "doi": "10.1016/j.mayocp.2017.10.009",
            "firstpage": "1806",
            "issn": "00256196",
            "lastpage": "1821",
            "pmid": "29202939",
            "pub_year": 2017,
            "title": "Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis",
            "volume": "92"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Jonas",
                    "initial": "J.",
                    "last": "Schmidt-Chanasit"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Sauerbrei"
                }
            ],
            "doi": "10.1016/j.meegid.2010.08.014",
            "firstpage": "1",
            "issn": "15671348",
            "lastpage": "10",
            "pmid": "20817040",
            "pub_year": 2011,
            "title": "Evolution and world-wide distribution of varicella-zoster virus clades",
            "volume": "11"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Himal",
                    "initial": "H.",
                    "last": "Lal"
                },
                {
                    "first": "Anthony L.",
                    "initial": "A.L.",
                    "last": "Cunningham"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Godeaux"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Diez-Domingo"
                },
                {
                    "first": "Shinn Jang",
                    "initial": "S.J.",
                    "last": "Hwang"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Janet E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "Airi",
                    "initial": "A.",
                    "last": "Poder"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Daisuke",
                    "initial": "D.",
                    "last": "Watanabe"
                },
                {
                    "first": "Lily",
                    "initial": "L.",
                    "last": "Weckx"
                },
                {
                    "first": "Toufik",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": "Thomas C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1056/NEJMoa1501184",
            "firstpage": "2087",
            "issn": "00284793",
            "lastpage": "2096",
            "pmid": "25916341",
            "pub_year": 2015,
            "title": "Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults",
            "volume": "372"
        },
        "b0045": {
            "authors": [
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Cunningham"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Lal"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Kovac"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Hwang"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "D\u00edez-Domingo"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Godeaux"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Vanden Abeele"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Watanabe"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ahonen"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Athan"
                },
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Barba-Gomez"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Campora"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "De Looze"
                },
                {
                    "first": "H. J.",
                    "initial": "H.J.",
                    "last": "Downey"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Ghesquiere"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Gorfinkel"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Korhonen"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Leung"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "McNeil"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Oostvogels"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Rombo"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Smetana"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Weckx"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Yeo"
                },
                {
                    "first": "T. C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                }
            ],
            "doi": "10.1056/NEJMoa1603800",
            "firstpage": "1019",
            "issn": "00284793",
            "lastpage": "1032",
            "pmid": "27626517",
            "pub_year": 2016,
            "title": "Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older",
            "volume": "375"
        },
        "b0050": null,
        "b0055": null,
        "b0060": null,
        "b0065": null,
        "b0070": null,
        "b0075": {
            "authors": [
                {
                    "first": "Kathleen L.",
                    "initial": "K.L.",
                    "last": "Dooling"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Guo"
                },
                {
                    "first": "Manisha",
                    "initial": "M.",
                    "last": "Patel"
                },
                {
                    "first": "Grace M.",
                    "initial": "G.M.",
                    "last": "Lee"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Moore"
                },
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                },
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Harpaz"
                }
            ],
            "doi": "10.15585/mmwr.mm6703a5",
            "firstpage": "103",
            "issn": "01492195",
            "lastpage": "108",
            "pmid": "29370152",
            "pub_year": 2018,
            "title": "Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines",
            "volume": "67"
        },
        "b0080": null,
        "b0085": null,
        "b0090": {
            "authors": [
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "L\u00f3pez-Fauqued"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Campora"
                },
                {
                    "first": "Fr\u00e9d\u00e9rique",
                    "initial": "F.",
                    "last": "Delannois"
                },
                {
                    "first": "Mohamed",
                    "initial": "M.",
                    "last": "El Idrissi"
                },
                {
                    "first": "Lidia",
                    "initial": "L.",
                    "last": "Oostvogels"
                },
                {
                    "first": "Ferdinandus J.",
                    "initial": "F.J.",
                    "last": "De Looze"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Diez-Domingo"
                },
                {
                    "first": "Thomas C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                },
                {
                    "first": "Himal",
                    "initial": "H.",
                    "last": "Lal"
                },
                {
                    "first": "Janet E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "Shelly A.",
                    "initial": "S.A.",
                    "last": "McNeil"
                },
                {
                    "first": "Wilfred",
                    "initial": "W.",
                    "last": "Yeo"
                },
                {
                    "first": "Fernanda",
                    "initial": "F.",
                    "last": "Tavares-Da-Silva"
                },
                {
                    "first": "Anitta",
                    "initial": "A.",
                    "last": "Ahonen"
                },
                {
                    "first": "Thiago Junquera",
                    "initial": "T.J.",
                    "last": "Avelino-Silva"
                },
                {
                    "first": "Jose Fernando",
                    "initial": "J.F.",
                    "last": "Barba-Gomez"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Berglund"
                },
                {
                    "first": "Carlos Brotons",
                    "initial": "C.B.",
                    "last": "Cuixart"
                },
                {
                    "first": "Covadonga",
                    "initial": "C.",
                    "last": "Caso"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "Won Suk",
                    "initial": "W.S.",
                    "last": "Choi"
                },
                {
                    "first": "Anthony L.",
                    "initial": "A.L.",
                    "last": "Cunningham"
                },
                {
                    "first": "Maria Guiseppina",
                    "initial": "M.G.",
                    "last": "Desole"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Eizenberg"
                },
                {
                    "first": "Meral",
                    "initial": "M.",
                    "last": "Esen"
                },
                {
                    "first": "Emmanuelle",
                    "initial": "E.",
                    "last": "Espi\u00e9"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Gervais"
                },
                {
                    "first": "Wayne",
                    "initial": "W.",
                    "last": "Ghesquiere"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Godeaux"
                },
                {
                    "first": "Iris",
                    "initial": "I.",
                    "last": "Gorfinkel"
                },
                {
                    "first": "David Shu Cheong",
                    "initial": "D.S.C.",
                    "last": "Hui"
                },
                {
                    "first": "Shinn Jang",
                    "initial": "S.J.",
                    "last": "Hwang"
                },
                {
                    "first": "Tiina",
                    "initial": "T.",
                    "last": "Korhonen"
                },
                {
                    "first": "Martina",
                    "initial": "M.",
                    "last": "Kovac"
                },
                {
                    "first": "Edouard",
                    "initial": "E.",
                    "last": "Ledent"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Leung"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Silvia Narejos",
                    "initial": "S.N.",
                    "last": "Perez"
                },
                {
                    "first": "Jose Luiz",
                    "initial": "J.L.",
                    "last": "Neto"
                },
                {
                    "first": "Karlis",
                    "initial": "K.",
                    "last": "Pauksens"
                },
                {
                    "first": "Airi",
                    "initial": "A.",
                    "last": "Poder"
                },
                {
                    "first": "Maria Luisa Rodriguez",
                    "initial": "M.L.R.",
                    "last": "de la Pinta"
                },
                {
                    "first": "Lars",
                    "initial": "L.",
                    "last": "Rombo"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Smetana"
                },
                {
                    "first": "Tommaso",
                    "initial": "T.",
                    "last": "Staniscia"
                },
                {
                    "first": "Juan Carlos",
                    "initial": "J.C.",
                    "last": "Tinoco"
                },
                {
                    "first": "Azhar",
                    "initial": "A.",
                    "last": "Toma"
                },
                {
                    "first": "Ilse",
                    "initial": "I.",
                    "last": "Vastiau"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Volpi"
                },
                {
                    "first": "Daisuke",
                    "initial": "D.",
                    "last": "Watanabe"
                },
                {
                    "first": "Lily Yin",
                    "initial": "L.Y.",
                    "last": "Weckx"
                },
                {
                    "first": "Toufik",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2019.03.043",
            "firstpage": "2482",
            "issn": "0264410X",
            "lastpage": "2493",
            "pmid": "30935742",
            "pub_year": 2019,
            "title": "Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials",
            "volume": "37"
        },
        "b0095": null,
        "b0100": null,
        "b0105": {
            "authors": [
                {
                    "first": "Craig M.",
                    "initial": "C.M.",
                    "last": "Hales"
                },
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Harpaz"
                },
                {
                    "first": "M. Riduan",
                    "initial": "M.R.",
                    "last": "Joesoef"
                },
                {
                    "first": "Stephanie R.",
                    "initial": "S.R.",
                    "last": "Bialek"
                }
            ],
            "doi": "10.7326/0003-4819-159-11-201312030-00006",
            "firstpage": "739",
            "issn": "00034819",
            "lastpage": "745",
            "pub_year": 2013,
            "title": "Examination of links between herpes zoster incidence and childhood varicella vaccination",
            "volume": "159"
        }
    },
    "body_text": [
        {
            "endOffset": 27044,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 27043,
                    "startOffset": 27040
                }
            },
            "secId": "s0040",
            "sentence": "The subgroups analyses of VE in the prevention of PHN was limited by the number of cases but appeared in line with the overall ZOE-50/70 population \u226570 YOA, in which RZV was 88.8% efficacious against PHN [9].",
            "startOffset": 26836,
            "title": "Discussion"
        },
        {
            "endOffset": 22161,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Most participants of African ancestry were enrolled in North America, and the majority of participants of Hispanic ethnicity were enrolled in Brazil and Mexico.",
            "startOffset": 22001,
            "title": "Study population results"
        },
        {
            "endOffset": 21314,
            "parents": [],
            "secId": "s0010",
            "sentence": "Geographic ancestry and ethnicity were self-reported.",
            "startOffset": 21261,
            "title": "Methods"
        },
        {
            "endOffset": 28212,
            "parents": [],
            "secId": "s0040",
            "sentence": "Due to the low number of subjects and outcomes in some subsets (i.e., participants of African ancestry and Hispanic ethnicity), efficacy could not be estimated or the confidence intervals for these estimates were broad.",
            "startOffset": 27993,
            "title": "Discussion"
        },
        {
            "endOffset": 17734,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 17733,
                    "startOffset": 17728
                },
                "b0045": {
                    "endOffset": 17733,
                    "startOffset": 17728
                }
            },
            "secId": "s0005",
            "sentence": "Over a period of >3 years, RZV demonstrated a 97.2% and 91.3% efficacy against HZ in adults \u226550 and \u226570 years of age (YOA), respectively, and, owing to the high efficacy against HZ, was also 91.2% and 88.8% efficacious in preventing PHN [8,9].",
            "startOffset": 17491,
            "title": "Introduction"
        },
        {
            "endOffset": 23277,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In the pooled ZOE-50/70 population \u226570 YOA, efficacy against PHN was 90.8% (95%CI: 36.4\u201399.8) in Asia/Australia, 86.8% (95%CI: 42.2\u201398.6) in Europe, and 100% (95%CI: 31.2\u2013100) in North America.",
            "startOffset": 23084,
            "title": "Efficacy against HZ and PHN according to geographic region"
        },
        {
            "endOffset": 26390,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 26389,
                    "startOffset": 26386
                }
            },
            "secId": "s0040",
            "sentence": "The distribution of circulating VZV clades has been reported to differ by region: for example, in Europe, clade 1 (50%) and clade 3 (37%) are predominant; in Oceania, clade 1 (52%) and clade 3 (22%), in America, clade 1 (70%), and in Asia, clade 2 (74%) [7].",
            "startOffset": 26132,
            "title": "Discussion"
        },
        {
            "endOffset": 19661,
            "parents": [],
            "secId": "s0010",
            "sentence": "Due to the low number of breakthrough events reported, efficacy against HZ according to geographic ancestry/ethnicity, as well as PHN in the subgroup calculations, was not estimated in \u226550-year-olds of the ZOE-50 study.",
            "startOffset": 19442,
            "title": "Methods"
        },
        {
            "endOffset": 21567,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "In the ZOE-50 study, vaccine efficacy was evaluated in 7340 RZV and in 7413 placebo recipients \u226550 YOA, having a mean age of 62.3 and 62.2 years, respectively (Table 1).",
            "startOffset": 21398,
            "title": "Study population results"
        },
        {
            "endOffset": 27875,
            "parents": [],
            "secId": "s0040",
            "sentence": "The ZOE-50/70 studies were powered to assess efficacy against HZ in each of these studies, and against PHN in the pooled study population.",
            "startOffset": 27737,
            "title": "Discussion"
        },
        {
            "endOffset": 26663,
            "parents": [],
            "secId": "s0040",
            "sentence": "Efficacy in \u226570-year-olds was also in similar ranges across these geographic regions, indicating that protection is similar against different clades.",
            "startOffset": 26514,
            "title": "Discussion"
        },
        {
            "endOffset": 25400,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 25399,
                    "startOffset": 25394
                },
                "b0045": {
                    "endOffset": 25399,
                    "startOffset": 25394
                }
            },
            "secId": "s0040",
            "sentence": "These subgroup efficacy results are similar to the overall ZOE-50/70 results [8,9].",
            "startOffset": 25317,
            "title": "Discussion"
        },
        {
            "endOffset": 16788,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 16787,
                    "startOffset": 16784
                }
            },
            "secId": "s0005",
            "sentence": "The occurrence of specific VZV clades varies in different regions of the world due to distinctive environmental factors, evolutionary conditions, host-virus interactions, and/or importation of viral strains [7].",
            "startOffset": 16577,
            "title": "Introduction"
        },
        {
            "endOffset": 16576,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 16575,
                    "startOffset": 16572
                }
            },
            "secId": "s0005",
            "sentence": "A recent systematic review of publications primarily from US, Canada, and Europe highlights that female sex and belonging to the white racial group may also increase risk for HZ [6].",
            "startOffset": 16394,
            "title": "Introduction"
        },
        {
            "endOffset": 18562,
            "parents": [],
            "secId": "s0010",
            "sentence": "The design of the ZOE-50/70 studies allowed pooling of efficacy data from participants \u226570 YOA (referred to as pooled ZOE-50/70 population \u226570 YOA hereafter).",
            "startOffset": 18404,
            "title": "Methods"
        },
        {
            "endOffset": 20179,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 20178,
                    "startOffset": 20175
                }
            },
            "secId": "s0010",
            "sentence": "PHN was defined as severe pain that persisted or developed more than 90 days after rash onset [9].",
            "startOffset": 20081,
            "title": "Methods"
        },
        {
            "endOffset": 22879,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In the ZOE-50 population \u226550 YOA, efficacy against HZ ranged from 95.7% (95%CI: 83.7\u2013100.0) for North America to 97.2% (95%CI: 91.4\u201399.5) for Europe.",
            "startOffset": 22730,
            "title": "Efficacy against HZ and PHN according to geographic region"
        },
        {
            "endOffset": 17884,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 17883,
                    "startOffset": 17876
                },
                "b0055": {
                    "endOffset": 17883,
                    "startOffset": 17876
                },
                "b0060": {
                    "endOffset": 17883,
                    "startOffset": 17876
                },
                "b0065": {
                    "endOffset": 17883,
                    "startOffset": 17876
                },
                "b0070": {
                    "endOffset": 17883,
                    "startOffset": 17876
                },
                "b0075": {
                    "endOffset": 17883,
                    "startOffset": 17876
                },
                "b0080": {
                    "endOffset": 17883,
                    "startOffset": 17876
                },
                "b0085": {
                    "endOffset": 17883,
                    "startOffset": 17876
                }
            },
            "secId": "s0005",
            "sentence": "RZV has received licensure in several countries for the prevention of HZ and (in some of these) PHN, and a recommended use in adults \u226550 YOA [10\u201317].",
            "startOffset": 17735,
            "title": "Introduction"
        },
        {
            "endOffset": 21260,
            "parents": [],
            "secId": "s0010",
            "sentence": "Geographic ancestries with a limited number of participants were grouped in Other ancestry (American Indian or Alaskan Native; Native Hawaiian or Other Pacific Islander or a person with several different heritages).",
            "startOffset": 21045,
            "title": "Methods"
        },
        {
            "endOffset": 24336,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "No PHN cases had occurred in participants of African ancestry and only a few PHN cases had occurred in participants of other ancestries or of Hispanic ethnicity.",
            "startOffset": 24175,
            "title": "Efficacy against HZ and PHN according to geographic ancestry/ethnicity"
        },
        {
            "endOffset": 26835,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 26834,
                    "startOffset": 26831
                }
            },
            "secId": "s0040",
            "sentence": "A pooled analysis of prospective cohort studies from North America, Latin America, and Asia shows a similar PHN risk in adults \u226550 YOA across these geographic regions [4].",
            "startOffset": 26664,
            "title": "Discussion"
        },
        {
            "endOffset": 22000,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "The majority of participants were enrolled in Europe (\u226551.6%) followed by Asia/Australia and North America.",
            "startOffset": 21893,
            "title": "Study population results"
        },
        {
            "endOffset": 25906,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 25905,
                    "startOffset": 25901
                }
            },
            "secId": "s0040",
            "sentence": "In addition, a retrospective study of Medicare claims in the US also showed that among adults \u226565 YOA, HZ incidence is higher in white persons compared to that of black or Hispanic persons [21].",
            "startOffset": 25712,
            "title": "Discussion"
        },
        {
            "endOffset": 22669,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "In the pooled ZOE-50/70 population \u226570 YOA, efficacy against PHN was 91.5% (95% confidence interval [CI]: 65.7\u201399.1) and 83.3% (95%CI: 24.8\u201398.2) in female and male participants, respectively (Fig. 2, Supplementary table 2).",
            "startOffset": 22445,
            "title": "Efficacy against HZ and PHN according to sex"
        },
        {
            "endOffset": 20080,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 20079,
                    "startOffset": 20074
                },
                "b0045": {
                    "endOffset": 20079,
                    "startOffset": 20074
                }
            },
            "secId": "s0010",
            "sentence": "Suspected HZ cases were confirmed by PCR, or if not possible by PCR, by unanimous agreement among the five members of an HZ ascertainment committee based on available clinical information, as described elsewhere [8,9].",
            "startOffset": 19862,
            "title": "Methods"
        },
        {
            "endOffset": 25999,
            "parents": [],
            "secId": "s0040",
            "sentence": "Our analysis shows a high efficacy against HZ irrespective of geographic ancestry/ethnicity.",
            "startOffset": 25907,
            "title": "Discussion"
        },
        {
            "endOffset": 27337,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 27336,
                    "startOffset": 27332
                }
            },
            "secId": "s0040",
            "sentence": "In line with the consistency of these subgroup analyses with overall efficacy findings, subgroup analyses on the pooled TVC of the ZOE-50/70 studies show no discrepancy between the safety profile of RZV in racial, ethnic, and gender subgroups and that in the overall ZOE-50/70 population [18].",
            "startOffset": 27044,
            "title": "Discussion"
        },
        {
            "endOffset": 24940,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 24939,
                    "startOffset": 24934
                },
                "b0045": {
                    "endOffset": 24939,
                    "startOffset": 24934
                }
            },
            "secId": "s0040",
            "sentence": "In the ZOE-50/70 trials, RZV demonstrated >90% efficacy against HZ in all age groups among adults \u226550 YOA, as well as high efficacy against PHN [8,9].",
            "startOffset": 24790,
            "title": "Discussion"
        },
        {
            "endOffset": 16043,
            "parents": [],
            "secId": "s0005",
            "sentence": "After primary infection (chickenpox), varicella-zoster virus (VZV) establishes life-long latency in the sensory cranial or dorsal root ganglia, and may later reactivate, resulting in herpes zoster (HZ), also known as shingles.",
            "startOffset": 15817,
            "title": "Introduction"
        },
        {
            "endOffset": 16298,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 16297,
                    "startOffset": 16294
                }
            },
            "secId": "s0005",
            "sentence": "The most frequent complication of HZ is postherpetic neuralgia (PHN), occurring in up to 30% of patients [4].",
            "startOffset": 16189,
            "title": "Introduction"
        },
        {
            "endOffset": 26132,
            "parents": [],
            "secId": "s0040",
            "sentence": "However, due to the limited sample size in some subgroups, robustness of efficacy data per geographic ancestry/ethnicity is limited.",
            "startOffset": 26000,
            "title": "Discussion"
        },
        {
            "endOffset": 24662,
            "parents": [],
            "secId": "s0040",
            "sentence": "Most HZ cases occur in older adults and in persons with other immune-compromising conditions.",
            "startOffset": 24569,
            "title": "Discussion"
        },
        {
            "endOffset": 18802,
            "parents": [],
            "secId": "s0010",
            "sentence": "Anonymized individual participant data and study documents may be requested for further research at www.clinicalstudydatarequest.com (study IDs 110390 and 113077).",
            "startOffset": 18639,
            "title": "Methods"
        },
        {
            "endOffset": 24174,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "In the pooled ZOE-50/70 population \u226570 YOA, efficacy against PHN was 87.5% (95%CI: 58.7\u201397.6) and 89.8% (95%CI: 28.5\u201399.8) in participants of European and Asian ancestry, respectively (Fig. 2, Supplementary table 2).",
            "startOffset": 23958,
            "title": "Efficacy against HZ and PHN according to geographic ancestry/ethnicity"
        },
        {
            "endOffset": 18638,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 18637,
                    "startOffset": 18633
                }
            },
            "secId": "s0010",
            "sentence": "Pooled safety data, also for sub-populations, are presented elsewhere [18].",
            "startOffset": 18563,
            "title": "Methods"
        },
        {
            "endOffset": 23646,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "In the pooled ZOE-50/70 population \u226570 YOA, efficacy against HZ ranged from 89.6% (95%CI: 83.5\u201393.8) to 100% (95%CI: <0\u2013100.0) in participants of European and African geographic ancestry, respectively.",
            "startOffset": 23445,
            "title": "Efficacy against HZ and PHN according to geographic ancestry/ethnicity"
        },
        {
            "endOffset": 20518,
            "parents": [],
            "secId": "s0010",
            "sentence": "The 18 participating countries were grouped by geographic regions: North America (Canada and the U.S.), Latin America (Brazil and Mexico), Europe (Czech Republic, Estonia, Finland, France, Germany, Italy, Spain, Sweden, and the United Kingdom), and Australia/Asia (Australia, Hong Kong, Japan, Republic of Korea [South Korea], and Taiwan).",
            "startOffset": 20179,
            "title": "Methods"
        },
        {
            "endOffset": 19261,
            "parents": [],
            "secId": "s0010",
            "sentence": "In these post-hoc analyses, VE against HZ and PHN was evaluated in \u226550 and/or in \u226570-year-olds included in the modified total vaccinated cohort (mTVC) of the ZOE-50 study and pooled mTVC from the ZOE-50/70 studies, respectively.",
            "startOffset": 19033,
            "title": "Methods"
        },
        {
            "endOffset": 18103,
            "parents": [],
            "secId": "s0005",
            "sentence": "Here, we present a post-hoc analysis of vaccine efficacy (VE) against HZ in the ZOE-50 population and in the pooled ZOE-50/70 population \u226570 YOA according to sex, geographic region, and/or geographic ancestry/ethnicity.",
            "startOffset": 17884,
            "title": "Introduction"
        },
        {
            "endOffset": 16188,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 16187,
                    "startOffset": 16182
                },
                "b0010": {
                    "endOffset": 16187,
                    "startOffset": 16182
                },
                "b0015": {
                    "endOffset": 16187,
                    "startOffset": 16182
                }
            },
            "secId": "s0005",
            "sentence": "It affects approximately 1 in 3 individuals in their lifetime, and is associated with significant morbidity and impact on quality of life [1\u20133].",
            "startOffset": 16044,
            "title": "Introduction"
        },
        {
            "endOffset": 27736,
            "parents": [],
            "secId": "s0040",
            "sentence": "By design, participants in the ZOE-50 and ZOE-70 studies were stratified by age and region and minimized by country and study site to ensure balance between the number of subjects in each group.",
            "startOffset": 27542,
            "title": "Discussion"
        },
        {
            "endOffset": 28389,
            "parents": [],
            "secId": "s0045",
            "sentence": "This post-hoc analysis confirmed that RZV is efficacious in preventing HZ and possibly PHN irrespective of sex, geographic region, and geographic ancestry/ethnicity.",
            "startOffset": 28224,
            "title": "Conclusions"
        },
        {
            "endOffset": 25559,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 25485,
                    "startOffset": 25482
                }
            },
            "secId": "s0040",
            "sentence": "While several studies have shown an increased risk of HZ in women compared to men [6], our analysis showed a similar efficacy of RZV against HZ for both sexes.",
            "startOffset": 25400,
            "title": "Discussion"
        },
        {
            "endOffset": 23848,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Hence, the 95%CI for the point estimate in this subset was broad, with a negative lower limit.",
            "startOffset": 23754,
            "title": "Efficacy against HZ and PHN according to geographic ancestry/ethnicity"
        },
        {
            "endOffset": 21768,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "More than half of participants were female.",
            "startOffset": 21725,
            "title": "Study population results"
        },
        {
            "endOffset": 21724,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "In the pooled ZOE-50/70 population \u226570 YOA, efficacy was evaluated in 8250 RZV and 8346 placebo recipients; the mean age was 75.5 years in each study group.",
            "startOffset": 21568,
            "title": "Study population results"
        },
        {
            "endOffset": 23958,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "In participants of Hispanic ethnicity, efficacy was 88.1% (95%CI: 61.2\u201397.7) (Fig. 1, Supplementary table 1).",
            "startOffset": 23849,
            "title": "Efficacy against HZ and PHN according to geographic ancestry/ethnicity"
        },
        {
            "endOffset": 25316,
            "parents": [],
            "secId": "s0040",
            "sentence": "Our post-hoc analyses confirmed that RZV is efficacious against HZ and PHN irrespective of sex, geographic region, and geographic ancestry/ethnicity.",
            "startOffset": 25167,
            "title": "Discussion"
        },
        {
            "endOffset": 26513,
            "parents": [],
            "secId": "s0040",
            "sentence": "Our data shows >95% RZV efficacy against HZ in adults \u226550 YOA across all four geographic regions included in our analysis.",
            "startOffset": 26391,
            "title": "Discussion"
        },
        {
            "endOffset": 18348,
            "parents": [],
            "secId": "s0010",
            "sentence": "The ZOE-50/70 clinical trials were conducted in parallel at the same centers.",
            "startOffset": 18271,
            "title": "Methods"
        },
        {
            "endOffset": 21044,
            "parents": [],
            "secId": "s0010",
            "sentence": "In the analyses by geographic ancestry/ethnicity, the following categories were used: European ancestry (Caucasian/European Heritage or Arabic/North African Heritage), Asian ancestry (Central/South Asian Heritage or East Asian Heritage or Japanese Heritage or Southeast Asian Heritage), African ancestry (African Heritage/African American), and Hispanic ethnicity (Hispanic or Latino; a person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of geographic ancestry).",
            "startOffset": 20519,
            "title": "Methods"
        },
        {
            "endOffset": 28512,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 28511,
                    "startOffset": 28506
                },
                "b0045": {
                    "endOffset": 28511,
                    "startOffset": 28506
                }
            },
            "secId": "s0045",
            "sentence": "RZV efficacy against HZ or PHN in these subgroups appears similar to that in the overall ZOE-50/70 study population [8,9].",
            "startOffset": 28390,
            "title": "Conclusions"
        },
        {
            "endOffset": 16393,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 16392,
                    "startOffset": 16387
                },
                "b0030": {
                    "endOffset": 16392,
                    "startOffset": 16387
                }
            },
            "secId": "s0005",
            "sentence": "Globally, the incidence of HZ increases with both age and immune-compromising conditions [5,6].",
            "startOffset": 16298,
            "title": "Introduction"
        },
        {
            "endOffset": 17490,
            "parents": [],
            "secId": "s0005",
            "sentence": "Protocol summaries are available at http://www.gsk-clinicalstudyregister.com (study IDs 110390 and 113077).",
            "startOffset": 17383,
            "title": "Introduction"
        },
        {
            "endOffset": 19033,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 19032,
                    "startOffset": 19027
                },
                "b0045": {
                    "endOffset": 19032,
                    "startOffset": 19027
                }
            },
            "secId": "s0010",
            "sentence": "Inclusion and exclusion criteria, as well as the composition of RZV have been described elsewhere [8,9].",
            "startOffset": 18929,
            "title": "Methods"
        },
        {
            "endOffset": 25166,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 25165,
                    "startOffset": 25158
                },
                "b0100": {
                    "endOffset": 25165,
                    "startOffset": 25158
                }
            },
            "secId": "s0040",
            "sentence": "In other trials, RZV has also been shown to be efficacious in preventing HZ in immunocompromised populations \u226518 YOA such as hematopoietic stem cell transplant recipients and in patients with hematologic malignancies [19,20].",
            "startOffset": 24941,
            "title": "Discussion"
        },
        {
            "endOffset": 18263,
            "parents": [],
            "secId": "s0005",
            "sentence": "In addition, we present efficacy against PHN in the pooled ZOE-50/70 population \u226570 YOA according to sex, geographic region, and geographic ancestry/ethnicity.",
            "startOffset": 18104,
            "title": "Introduction"
        },
        {
            "endOffset": 19862,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 19694,
                    "startOffset": 19691
                }
            },
            "secId": "s0010",
            "sentence": "Since PHN increases with age [4], this allowed for an estimation of VE against PHN as a primary objective for the pooled ZOE-50/70 population \u226570 YOA, for which subgroup analyses are presented herein.",
            "startOffset": 19662,
            "title": "Methods"
        },
        {
            "endOffset": 22444,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0025",
            "sentence": "Point estimates for efficacy against HZ were >90% in both female and male participants in the ZOE-50/70 populations (Fig. 1, Supplementary table 1).",
            "startOffset": 22296,
            "title": "Efficacy against HZ and PHN according to sex"
        },
        {
            "endOffset": 17046,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, non-biological factors such as differences in healthcare seeking behavior and diagnostic/surveillance practices for HZ across countries may explain observed differences in the incidence of HZ by sex and geographic ancestry/ethnicity to some extent.",
            "startOffset": 16789,
            "title": "Introduction"
        },
        {
            "endOffset": 28676,
            "parents": [],
            "secId": "s0045",
            "sentence": "A plain language summary contextualizing the results and potential clinical research relevance and impact is displayed in the Focus on the Patient Section (Fig. 3).",
            "startOffset": 28512,
            "title": "Conclusions"
        },
        {
            "endOffset": 22249,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Demographic characteristics were balanced between RZV and placebo recipients (Table 1).",
            "startOffset": 22162,
            "title": "Study population results"
        },
        {
            "endOffset": 21363,
            "parents": [],
            "secId": "s0010",
            "sentence": "All statistical analyses were executed using SAS.",
            "startOffset": 21314,
            "title": "Methods"
        },
        {
            "endOffset": 23372,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "The number of PHN cases for Latin America was insufficient to allow estimation of VE (Fig. 2).",
            "startOffset": 23278,
            "title": "Efficacy against HZ and PHN according to geographic region"
        },
        {
            "endOffset": 27541,
            "parents": [],
            "secId": "s0040",
            "sentence": "The ZOE-50/70 studies were not powered to assess efficacy against HZ nor against PHN in specific sub-populations.",
            "startOffset": 27428,
            "title": "Discussion"
        },
        {
            "endOffset": 27992,
            "parents": [],
            "secId": "s0040",
            "sentence": "In most subsets, enough HZ or PHN cases had occurred to allow the assessment of VE against HZ and PHN, respectively.",
            "startOffset": 27876,
            "title": "Discussion"
        },
        {
            "endOffset": 18403,
            "parents": [],
            "secId": "s0010",
            "sentence": "Adults \u226570 YOA were randomly assigned to either trial.",
            "startOffset": 18349,
            "title": "Methods"
        },
        {
            "endOffset": 23084,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "In the pooled ZOE-50/70 population \u226570 YOA, efficacy estimates for HZ ranged from 87.3% (95%CI: 58.1\u201397.6) for Latin America to 95.1% (95%CI: 87.0\u201398.7) for Asia/Australia (Fig. 1, Supplementary table 1).",
            "startOffset": 22880,
            "title": "Efficacy against HZ and PHN according to geographic region"
        },
        {
            "endOffset": 24789,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 24788,
                    "startOffset": 24785
                }
            },
            "secId": "s0040",
            "sentence": "Other factors such as female sex or belonging to the white racial group have been associated with an increased risk of HZ [6].",
            "startOffset": 24663,
            "title": "Discussion"
        },
        {
            "endOffset": 18928,
            "parents": [],
            "secId": "s0010",
            "sentence": "Adults \u226550 YOA (ZOE-50) or \u226570 YOA (ZOE-70) were randomized 1:1 to receive 2 doses of either RZV or of placebo 2 months apart.",
            "startOffset": 18802,
            "title": "Methods"
        },
        {
            "endOffset": 24558,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Hence, efficacy against PHN could not be estimated for the African ancestry subgroup, while for the remaining ancestries and Hispanic ethnicity, the 95% CIs for the point estimates were broad, with a negative lower limit.",
            "startOffset": 24337,
            "title": "Efficacy against HZ and PHN according to geographic ancestry/ethnicity"
        },
        {
            "endOffset": 19441,
            "parents": [],
            "secId": "s0010",
            "sentence": "These cohorts consisted of all vaccinated participants who received both doses and who did not develop a confirmed HZ episode in the period between dose 1 and 30 days post-dose 2.",
            "startOffset": 19262,
            "title": "Methods"
        },
        {
            "endOffset": 23753,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "However, among participants with an African ancestry, only 1 placebo recipient had a confirmed HZ episode.",
            "startOffset": 23647,
            "title": "Efficacy against HZ and PHN according to geographic ancestry/ethnicity"
        },
        {
            "endOffset": 25711,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 25710,
                    "startOffset": 25707
                }
            },
            "secId": "s0040",
            "sentence": "This recent meta-analysis also showed that the risk of HZ in white persons is approximately two-fold higher when compared to that in black persons [6].",
            "startOffset": 25560,
            "title": "Discussion"
        },
        {
            "endOffset": 21892,
            "parents": [
                {
                    "id": "s0015",
                    "title": "Results"
                }
            ],
            "secId": "s0020",
            "sentence": "Most participants were of European ancestry, followed by Asian and African ancestry, and \u226410.9% were of Hispanic ethnicity.",
            "startOffset": 21769,
            "title": "Study population results"
        },
        {
            "endOffset": 17382,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 17381,
                    "startOffset": 17376
                },
                "b0045": {
                    "endOffset": 17381,
                    "startOffset": 17376
                }
            },
            "secId": "s0005",
            "sentence": "Two large-scale, randomized, observer-blind, placebo-controlled trials evaluated the efficacy and safety of the adjuvanted recombinant zoster vaccine (RZV) against HZ in adults aged \u226550 years (ZOE-50, NCT01165177) and \u226570 years (ZOE-70, NCT01165229) across 18 countries in North America, Latin America, Europe, and Australia/Asia [8,9].",
            "startOffset": 17046,
            "title": "Introduction"
        },
        {
            "endOffset": 27427,
            "parents": [],
            "secId": "s0040",
            "sentence": "This post-hoc analysis has limitations and its results should be interpreted with caution.",
            "startOffset": 27337,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19312289",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "david.o.willer@gsk.com",
                "first": "David O.",
                "initial": "D.O.",
                "last": "Willer"
            },
            {
                "email": "cornelia.oostvogels@orange.fr",
                "first": "Lidia",
                "initial": "L.",
                "last": "Oostvogels"
            },
            {
                "email": "tony.cunningham@sydney.edu.au",
                "first": "Anthony L.",
                "initial": "A.L.",
                "last": "Cunningham"
            },
            {
                "email": "pierre.gervais@qtresearch.com",
                "first": "Pierre",
                "initial": "P.",
                "last": "Gervais"
            },
            {
                "email": "i.gor@outlook.com",
                "first": "Iris",
                "initial": "I.",
                "last": "Gorfinkel"
            },
            {
                "email": "joon-hyung.k.kim@gsk.com",
                "first": "Joon",
                "initial": "J.",
                "last": "Hyung Kim"
            },
            {
                "email": "carla.a.talarico@gsk.com",
                "first": "Carla",
                "initial": "C.",
                "last": "Talarico"
            },
            {
                "email": "valentine.v.wascotte@gsk.com",
                "first": "Valentine",
                "initial": "V.",
                "last": "Wascotte"
            },
            {
                "email": "toufik.zahaf@gsk.com",
                "first": "Toufik",
                "initial": "T.",
                "last": "Zahaf"
            },
            {
                "email": "romcolindres@hotmail.com",
                "first": "Romulo",
                "initial": "R.",
                "last": "Colindres"
            },
            {
                "email": "anne.a.schuind@gsk.com",
                "first": "Anne",
                "initial": "A.",
                "last": "Schuind"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.09.028",
        "firstpage": "6262",
        "issn": "0264410X",
        "keywords": [
            "Efficacy",
            "Geographic ancestry/ethnicity",
            "Herpes zoster",
            "Recombinant zoster vaccine",
            "Region",
            "Sex"
        ],
        "lastpage": "6267",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials"
    }
}